The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Synthetic Blood Substitutes and Blood Product Market Research Report 2025
Synopsis
Artificial blood replacement in the human body is referred to as synthetic blood substitutes. A blood replacement is a substance that is utilised to meet the biological needs of the body that are not met by real blood. A set of chemicals made consisting of carbon and fluorine are used to create artificial blood. These molecules may dissolve 50 times more oxygen into the body than blood plasma. Internally, the molecules work similarly to blood, supplying oxygen to different regions of the body, organs, and tissues.Patients suffer massive blood loss as a result of catastrophic injuries and diseases, resulting in the deaths of thousands of patients each year. Fresh blood also has a 42-hour life span. Because of this obstacle, synthetic blood substitutes are required to meet the patient's immediate blood supply needs and to extend his or her life.
Global Synthetic Blood Substitutes and Blood Product market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Synthetic Blood Substitutes and Blood Product market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Synthetic Blood Substitutes and Blood Product market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Aurum Biosciences Ltd
Hemarina SA
KaloCyte Inc.
NuvOx Pharma LLC
Northfield Laboratories
Dentritech, Inc.
HemoBioTech, Inc.
Dextro-Sang Corp.
Baxter International
FluorO2 Therapeutics
Alpha Therapeutic Corp.
Hemoglobin Oxygen Therapeutics LLC
SpheriTech Ltd
Sangart, Inc.
BioPure
PHORNANO Holding GmbH
Segment by Type
Human Blood
Animal Blood
Microorganisms
Synthetic Polymers
Stem Cells
Others
Segment by Application
Hospitals and Clinics
Blood Banks
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Synthetic Blood Substitutes and Blood Product report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Artificial blood replacement in the human body is referred to as synthetic blood substitutes. A blood replacement is a substance that is utilised to meet the biological needs of the body that are not met by real blood. A set of chemicals made consisting of carbon and fluorine are used to create artificial blood. These molecules may dissolve 50 times more oxygen into the body than blood plasma. Internally, the molecules work similarly to blood, supplying oxygen to different regions of the body, organs, and tissues.Patients suffer massive blood loss as a result of catastrophic injuries and diseases, resulting in the deaths of thousands of patients each year. Fresh blood also has a 42-hour life span. Because of this obstacle, synthetic blood substitutes are required to meet the patient's immediate blood supply needs and to extend his or her life.
Global Synthetic Blood Substitutes and Blood Product market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Synthetic Blood Substitutes and Blood Product market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Synthetic Blood Substitutes and Blood Product market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Aurum Biosciences Ltd
Hemarina SA
KaloCyte Inc.
NuvOx Pharma LLC
Northfield Laboratories
Dentritech, Inc.
HemoBioTech, Inc.
Dextro-Sang Corp.
Baxter International
FluorO2 Therapeutics
Alpha Therapeutic Corp.
Hemoglobin Oxygen Therapeutics LLC
SpheriTech Ltd
Sangart, Inc.
BioPure
PHORNANO Holding GmbH
Segment by Type
Human Blood
Animal Blood
Microorganisms
Synthetic Polymers
Stem Cells
Others
Segment by Application
Hospitals and Clinics
Blood Banks
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Synthetic Blood Substitutes and Blood Product report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Synthetic Blood Substitutes and Blood Product Market Overview
1.1 Product Overview and Scope of Synthetic Blood Substitutes and Blood Product
1.2 Synthetic Blood Substitutes and Blood Product Segment by Type
1.2.1 Global Synthetic Blood Substitutes and Blood Product Market Value Comparison by Type (2023-2029)
1.2.2 Human Blood
1.2.3 Animal Blood
1.2.4 Microorganisms
1.2.5 Synthetic Polymers
1.2.6 Stem Cells
1.2.7 Others
1.3 Synthetic Blood Substitutes and Blood Product Segment by Application
1.3.1 Global Synthetic Blood Substitutes and Blood Product Market Value by Application: (2023-2029)
1.3.2 Hospitals and Clinics
1.3.3 Blood Banks
1.3.4 Others
1.4 Global Synthetic Blood Substitutes and Blood Product Market Size Estimates and Forecasts
1.4.1 Global Synthetic Blood Substitutes and Blood Product Revenue 2018-2029
1.4.2 Global Synthetic Blood Substitutes and Blood Product Sales 2018-2029
1.4.3 Global Synthetic Blood Substitutes and Blood Product Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Synthetic Blood Substitutes and Blood Product Market Competition by Manufacturers
2.1 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Manufacturers (2018-2023)
2.2 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Synthetic Blood Substitutes and Blood Product Average Price by Manufacturers (2018-2023)
2.4 Global Synthetic Blood Substitutes and Blood Product Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Product Type & Application
2.7 Synthetic Blood Substitutes and Blood Product Market Competitive Situation and Trends
2.7.1 Synthetic Blood Substitutes and Blood Product Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Synthetic Blood Substitutes and Blood Product Players Market Share by Revenue
2.7.3 Global Synthetic Blood Substitutes and Blood Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Synthetic Blood Substitutes and Blood Product Retrospective Market Scenario by Region
3.1 Global Synthetic Blood Substitutes and Blood Product Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Synthetic Blood Substitutes and Blood Product Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2018-2029
3.2.1 Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2018-2023
3.2.2 Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2024-2029
3.3 Global Synthetic Blood Substitutes and Blood Product Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2018-2029
3.3.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2018-2023
3.3.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2024-2029
3.4 North America Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.4.1 North America Synthetic Blood Substitutes and Blood Product Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Synthetic Blood Substitutes and Blood Product Sales by Country (2018-2029)
3.4.3 North America Synthetic Blood Substitutes and Blood Product Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.5.1 Europe Synthetic Blood Substitutes and Blood Product Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Synthetic Blood Substitutes and Blood Product Sales by Country (2018-2029)
3.5.3 Europe Synthetic Blood Substitutes and Blood Product Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.6.1 Asia Pacific Synthetic Blood Substitutes and Blood Product Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Synthetic Blood Substitutes and Blood Product Sales by Country (2018-2029)
3.6.3 Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.7.1 Latin America Synthetic Blood Substitutes and Blood Product Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Synthetic Blood Substitutes and Blood Product Sales by Country (2018-2029)
3.7.3 Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Synthetic Blood Substitutes and Blood Product Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Synthetic Blood Substitutes and Blood Product Sales by Country (2018-2029)
3.8.3 Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Synthetic Blood Substitutes and Blood Product Sales by Type (2018-2029)
4.1.1 Global Synthetic Blood Substitutes and Blood Product Sales by Type (2018-2023)
4.1.2 Global Synthetic Blood Substitutes and Blood Product Sales by Type (2024-2029)
4.1.3 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Type (2018-2029)
4.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2018-2029)
4.2.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2018-2023)
4.2.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2024-2029)
4.2.3 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Type (2018-2029)
4.3 Global Synthetic Blood Substitutes and Blood Product Price by Type (2018-2029)
5 Segment by Application
5.1 Global Synthetic Blood Substitutes and Blood Product Sales by Application (2018-2029)
5.1.1 Global Synthetic Blood Substitutes and Blood Product Sales by Application (2018-2023)
5.1.2 Global Synthetic Blood Substitutes and Blood Product Sales by Application (2024-2029)
5.1.3 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Application (2018-2029)
5.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2018-2029)
5.2.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2018-2023)
5.2.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2024-2029)
5.2.3 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Application (2018-2029)
5.3 Global Synthetic Blood Substitutes and Blood Product Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aurum Biosciences Ltd
6.1.1 Aurum Biosciences Ltd Corporation Information
6.1.2 Aurum Biosciences Ltd Description and Business Overview
6.1.3 Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Product Portfolio
6.1.5 Aurum Biosciences Ltd Recent Developments/Updates
6.2 Hemarina SA
6.2.1 Hemarina SA Corporation Information
6.2.2 Hemarina SA Description and Business Overview
6.2.3 Hemarina SA Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Hemarina SA Synthetic Blood Substitutes and Blood Product Product Portfolio
6.2.5 Hemarina SA Recent Developments/Updates
6.3 KaloCyte Inc.
6.3.1 KaloCyte Inc. Corporation Information
6.3.2 KaloCyte Inc. Description and Business Overview
6.3.3 KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.3.4 KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.3.5 KaloCyte Inc. Recent Developments/Updates
6.4 NuvOx Pharma LLC
6.4.1 NuvOx Pharma LLC Corporation Information
6.4.2 NuvOx Pharma LLC Description and Business Overview
6.4.3 NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Product Portfolio
6.4.5 NuvOx Pharma LLC Recent Developments/Updates
6.5 Northfield Laboratories
6.5.1 Northfield Laboratories Corporation Information
6.5.2 Northfield Laboratories Description and Business Overview
6.5.3 Northfield Laboratories Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Northfield Laboratories Synthetic Blood Substitutes and Blood Product Product Portfolio
6.5.5 Northfield Laboratories Recent Developments/Updates
6.6 Dentritech, Inc.
6.6.1 Dentritech, Inc. Corporation Information
6.6.2 Dentritech, Inc. Description and Business Overview
6.6.3 Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.6.5 Dentritech, Inc. Recent Developments/Updates
6.7 HemoBioTech, Inc.
6.6.1 HemoBioTech, Inc. Corporation Information
6.6.2 HemoBioTech, Inc. Description and Business Overview
6.6.3 HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.7.5 HemoBioTech, Inc. Recent Developments/Updates
6.8 Dextro-Sang Corp.
6.8.1 Dextro-Sang Corp. Corporation Information
6.8.2 Dextro-Sang Corp. Description and Business Overview
6.8.3 Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.8.5 Dextro-Sang Corp. Recent Developments/Updates
6.9 Baxter International
6.9.1 Baxter International Corporation Information
6.9.2 Baxter International Description and Business Overview
6.9.3 Baxter International Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Baxter International Synthetic Blood Substitutes and Blood Product Product Portfolio
6.9.5 Baxter International Recent Developments/Updates
6.10 FluorO2 Therapeutics
6.10.1 FluorO2 Therapeutics Corporation Information
6.10.2 FluorO2 Therapeutics Description and Business Overview
6.10.3 FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.10.4 FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Product Portfolio
6.10.5 FluorO2 Therapeutics Recent Developments/Updates
6.11 Alpha Therapeutic Corp.
6.11.1 Alpha Therapeutic Corp. Corporation Information
6.11.2 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Description and Business Overview
6.11.3 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.11.5 Alpha Therapeutic Corp. Recent Developments/Updates
6.12 Hemoglobin Oxygen Therapeutics LLC
6.12.1 Hemoglobin Oxygen Therapeutics LLC Corporation Information
6.12.2 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Description and Business Overview
6.12.3 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Product Portfolio
6.12.5 Hemoglobin Oxygen Therapeutics LLC Recent Developments/Updates
6.13 SpheriTech Ltd
6.13.1 SpheriTech Ltd Corporation Information
6.13.2 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Description and Business Overview
6.13.3 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.13.4 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Product Portfolio
6.13.5 SpheriTech Ltd Recent Developments/Updates
6.14 Sangart, Inc.
6.14.1 Sangart, Inc. Corporation Information
6.14.2 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Description and Business Overview
6.14.3 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio
6.14.5 Sangart, Inc. Recent Developments/Updates
6.15 BioPure
6.15.1 BioPure Corporation Information
6.15.2 BioPure Synthetic Blood Substitutes and Blood Product Description and Business Overview
6.15.3 BioPure Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.15.4 BioPure Synthetic Blood Substitutes and Blood Product Product Portfolio
6.15.5 BioPure Recent Developments/Updates
6.16 PHORNANO Holding GmbH
6.16.1 PHORNANO Holding GmbH Corporation Information
6.16.2 PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Description and Business Overview
6.16.3 PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2018-2023)
6.16.4 PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Product Portfolio
6.16.5 PHORNANO Holding GmbH Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Synthetic Blood Substitutes and Blood Product Industry Chain Analysis
7.2 Synthetic Blood Substitutes and Blood Product Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Synthetic Blood Substitutes and Blood Product Production Mode & Process
7.4 Synthetic Blood Substitutes and Blood Product Sales and Marketing
7.4.1 Synthetic Blood Substitutes and Blood Product Sales Channels
7.4.2 Synthetic Blood Substitutes and Blood Product Distributors
7.5 Synthetic Blood Substitutes and Blood Product Customers
8 Synthetic Blood Substitutes and Blood Product Market Dynamics
8.1 Synthetic Blood Substitutes and Blood Product Industry Trends
8.2 Synthetic Blood Substitutes and Blood Product Market Drivers
8.3 Synthetic Blood Substitutes and Blood Product Market Challenges
8.4 Synthetic Blood Substitutes and Blood Product Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
